Multidrug resistance in pediatric urinary tract infections

Microbial Drug Resistance

Volumn 12, Issue 2, 2006, Pages 126-129

  Gaspari, Romolo J ^a   Dickson, Eric ^b   Karlowsky, James ^b,d   Doern, Gary ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Focus Technologies Incorporated   (United States)

^d W189Z General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; DATA BASE; FEMALE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; URINARY TRACT INFECTION; URINE CULTURE; UROPATHOGENIC ESCHERICHIA COLI;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; HUMANS; INFANT; INFANT, NEWBORN; URINARY TRACT INFECTIONS;

ESCHERICHIA COLI;

EID: 33746745418     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.12.126     Document Type: Article

References (24)

1. al-Mugeiren, M.M., and S.M. Qadri. 1996. Bacteriologic profile and drug resistance in pediatric patients with symptomatic bacteriuria. Clin. Ther. 18:295-300.
2. Fanos, V., and B.J. Khoory. 1999. Antimicrobial survey of urinary tract isolates from a pediatric department. J. Chemother. 11:255-259.
3. Fluit, A.C., M.E. Jones, F.J. Schmitz, et al. 2000. Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997. Antonie Van Leeuwenhoek 77:147-152.
4. Gales, A.C., R.N. Jones, K.A. Gordon, et al. 2000. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). J. Antimicrob. Chemother. 45:295-303.
5. Gaspari, R.J., E. Dickson, J. Karlowsky, et al. 2005. Antibiotic resistance trends in paediatric uropathogens. Int. J. Antimicrob. Agents 26:267-271.
6. Goettsch, W., W. van Pelt, N. Nagelkerke, et al. 2000. Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands. J. Antimicrob. Chemother. 46:223-228.
7. Gupta, K., D. Scholes, and W.E. Stamm. 1999. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. J. Am. Med. Assn. 281:736-738.
8. Gupta, K., T.M. Hooton, and W.E. Stamm. 2001. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann. Intern. Med. 135:41-50.
9. Gupta, K., D.F. Sahm, D. Mayfield, et al. 2001. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin. Infect. Dis. 33:89-94.
10. Gur, D., G. Kanra, M. Ceyhan, et al. 1999. Epidemiology and antibiotic resistance of gram-negative urinary pathogens in pediatric patients. Turk. J. Pediatr. 41:37-42.
11. Jones, R.N., P.L. Winokur, M.A. Pfaller, et al. 1999. Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program (1997). Clin. Microbiol. Infect. 5:478-487.
12. Kahlmeter, G. 2000. The ECO*SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J. Antimicrob. Chemother. 46(Suppl. A):15-22.
13. Karlowsky, J.A.T.C.P.D. 2001. Antimicrobial resistance among Escherichia coli urinary tract isolates in the United States: a current view provided by electronic surveillance. Infect. Dis. Clin. Prac. 10:87-92.
14. Le, T.P., and L.G. Miller. 2001. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. Clin. Infect. Dis. 33:615-621.
15. McCarty, J.M., G. Richard, W. Huck, et al. 1999. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am. J. Med. 106:292-299.
16. National Committee for Clinical Laboratory Standards. (2002). Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. Approved standard M100-S12. 2002, National Committee for Clinical Laboratory Standards, Wayne, PA.
17. Nicolle, L.E., A.I. Hoepelman, M. Floor, et al. 1993. Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection. Scand. J. Infect. Dis. 25:631-637.
18. Prado, V., O. Trucco, C. Duran, et al. 2001. Profile of antimicrobial resistance of agents causing urinary tract infections in Chilean children. PRONARES surveillance program. Rev. Med. Chil. 129:877-885.
19. Sahm, D.F., M.K. Marsilio, and G. Piazza. 1999. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database - USA. Clin. Infect. Dis. 29:259-263.
20. Sahm, D.F., C. Thornsberry, D.C. Mayfield, et al. 2001. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents. Chemother. 2001. 45:1402-1406.
21. Talan, D.A., W.E. Stamm, T.M. Hooton, et al. 2000. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial. J. Am. Med. Assn. 283:1583-1590.
22. Vu-Thien, H. 1998. Antibiotic sensitivity to isolated bacteria in pediatric urinary tract infections. Arch. Pediatr. 5(Suppl. 3):266S-268S.
23. Warren, J.W., E. Abrutyn, J.R. Hebel, et al. 1999. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin. Infect. Dis. 29:745-758.
24. Wright, S.W., K.D. Wrenn, M. Haynes, et al. 2000. Prevalence and risk factors for multidrug resistant uropathogens in ED patients. Am. J. Emerg. Med. 18:143-146.